HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Continuous oral cyclophosphamide and prednisolone as a valuable treatment option for peripheral T cell lymphoma.

AuthorsAlessandra Tucci, Elisa Cerqui, Marco Ungari, Samantha Ferrari, Liliana Baushi, Fabio Facchetti, Giuseppe Rossi
JournalBritish journal of haematology (Br J Haematol) Vol. 152 Issue 1 Pg. 113-6 (Jan 2011) ISSN: 1365-2141 [Electronic] England
PMID20880109 (Publication Type: Letter)
Chemical References
  • Cyclophosphamide
  • Prednisolone
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Cyclophosphamide (administration & dosage)
  • Drug Administration Schedule
  • Female
  • Humans
  • Lymphoma, T-Cell, Peripheral (drug therapy)
  • Male
  • Middle Aged
  • Prednisolone (administration & dosage)
  • Retrospective Studies
  • Survival Analysis
  • Treatment Outcome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: